(Q40362146)

English

Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.

scientific article published on April 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

based on heuristic

inferred from title

tumor-infiltrating immune cell

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

N Okada

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A Sasaki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M Niwa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Y Okada

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Y Hatanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Y Tani

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

H Mizuguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

S Nakagawa

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A Yamamoto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

393-405

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Chemokines in immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

The molecular biology of leukocyte chemoattractant receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Melanoma and stroma: an interaction of biological and prognostic importance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Lymphocyte traffic control by chemokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant Antitumor Effects Obtained by Autologous Tumor Cell Vaccine Engineered to Secrete Interleukin (IL)-12 and IL-18 by Means of the EBV/Lipoplex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune surveillance and effector functions of CCR10(+) skin homing T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700903

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700903

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16224496%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40362146&oldid=2203630864"